Dating back to 25 years since the HIV epidemic took hold in many countries, research studies suggested a possible increased risk of HIV acquisition for women using progestogen-only injectables like DMPA-intramuscular (DMPA-IM), Levonorgestrel and Copper-bearing IUD. However, it was not possible to determine whether HIV infections were due to the type of contraceptive method used or other factors because of limitations in the design of these studies. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study was carried out in four countries with settings of high HIV incidence ‒ Eswatini, Kenya, South Africa and Zambia. Results of the ECHO trial found no significant difference in risk of HIV infection among women using one of three highly effective, reversible contraceptive methods. Read more about this here.
Excerpt from WHO Press Release
New Study Finds No Link between HIV Infection and Contraceptive Methods